CD117-ADC at doses resulting in robust engraftment with genetically modified cells is also not associated in our studies or predicted to cause infertility, veno-occlusive disease, pulmonary dysfunction, mucositis, or seizures, in contrast to busulfan. The gene discussed is KIT; the disease is hepatic veno-occlusive disease.